Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Cook

Showing results (611-620 of 623) with videos related to

Pageof 63
Sort By:
The Journal of Allergy and Clinical Immunology|May 16, 2017
NIAID, NIEHS, NHLBI, and MCAN Workshop Report: The indoor environment and childhood asthma-implications for home environmental intervention in asthma prevention and managementDiane R Gold, Gary Adamkiewicz, Syed Hasan Arshad, et al.
Nature Immunology|June 4, 2024
Cell shape sensing licenses dendritic cells for homeostatic migration to lymph nodesZahraa Alraies, Claudia A Rivera, Maria-Graciela Delgado, et al.
Journal of Medicinal Chemistry|February 8, 2019
Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic FilariasisRobert T Jacobs, Christopher S Lunde, Yvonne R Freund, et al.
Conservation Letters|March 12, 2026
A Standardized Definition of Rapid Evidence Assessment for Environmental ApplicationsJ Angus Webb, Kate A Schofield, Carly N Cook, et al.
Science Translational Medicine|March 15, 2019
Preclinical development of an oral anti-<i>Wolbachia</i> macrolide drug for the treatment of lymphatic filariasis and onchocerciasisMark J Taylor, Thomas W von Geldern, Louise Ford, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2019
AWZ1066S, a highly specific anti-<i>Wolbachia</i> drug candidate for a short-course treatment of filariasisW David Hong, Farid Benayoud, Gemma L Nixon, et al.
Journal of Medicinal Chemistry|April 26, 2016
The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 KinasePamela A Haile, Bartholomew J Votta, Robert W Marquis, et al.
Nature|February 24, 2022
TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13AX Rosa Ma, Mercedes Prudencio, Yuka Koike, et al.
Science (New York, N.Y.)|August 13, 2016
Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcriptsNicholas J Kramer, Yari Carlomagno, Yong-Jie Zhang, et al.
Science (New York, N.Y.)|October 9, 2025
Covalent inhibitors of the PI3Kα RAS binding domain impair tumor growth driven by RAS and HER2Joseph E Klebba, Nilotpal Roy, Steffen M Bernard, et al.
Pageof 63

Showing results (611-620 of 623) with videos related to

Sort By:
Pageof 63
The Journal of Allergy and Clinical Immunology|May 16, 2017
NIAID, NIEHS, NHLBI, and MCAN Workshop Report: The indoor environment and childhood asthma-implications for home environmental intervention in asthma prevention and managementDiane R Gold, Gary Adamkiewicz, Syed Hasan Arshad, et al.
Nature Immunology|June 4, 2024
Cell shape sensing licenses dendritic cells for homeostatic migration to lymph nodesZahraa Alraies, Claudia A Rivera, Maria-Graciela Delgado, et al.
Journal of Medicinal Chemistry|February 8, 2019
Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic FilariasisRobert T Jacobs, Christopher S Lunde, Yvonne R Freund, et al.
Conservation Letters|March 12, 2026
A Standardized Definition of Rapid Evidence Assessment for Environmental ApplicationsJ Angus Webb, Kate A Schofield, Carly N Cook, et al.
Science Translational Medicine|March 15, 2019
Preclinical development of an oral anti-<i>Wolbachia</i> macrolide drug for the treatment of lymphatic filariasis and onchocerciasisMark J Taylor, Thomas W von Geldern, Louise Ford, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2019
AWZ1066S, a highly specific anti-<i>Wolbachia</i> drug candidate for a short-course treatment of filariasisW David Hong, Farid Benayoud, Gemma L Nixon, et al.
Journal of Medicinal Chemistry|April 26, 2016
The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 KinasePamela A Haile, Bartholomew J Votta, Robert W Marquis, et al.
Nature|February 24, 2022
TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13AX Rosa Ma, Mercedes Prudencio, Yuka Koike, et al.
Science (New York, N.Y.)|August 13, 2016
Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcriptsNicholas J Kramer, Yari Carlomagno, Yong-Jie Zhang, et al.
Science (New York, N.Y.)|October 9, 2025
Covalent inhibitors of the PI3Kα RAS binding domain impair tumor growth driven by RAS and HER2Joseph E Klebba, Nilotpal Roy, Steffen M Bernard, et al.
Pageof 63